Home » Authors » Jim Shrine

Articles by Jim Shrine

Precision Therapeutics slates IPO for personalized platform

Aug. 30, 2007

PDL Selling Cardio Programs, Ending Pivotal Nuvion Trials

Aug. 30, 2007

PDL Selling Cardio Programs, Ending Pivotal Nuvion Trials

Aug. 30, 2007

Indevus Files For FDA Approval For Long-Acting Testosterone

Aug. 29, 2007

Indevus Files For FDA Approval For Long-Acting Testosterone

Aug. 29, 2007

Upstream Completes Acquisition Of Firm Focused On Parasites

Aug. 28, 2007

Precision Therapeutics plans IPO for personalized platform

Aug. 28, 2007

Upstream Completes Acquisition Of Firm Focused On Parasites

Aug. 28, 2007

Precision Therapeutics Plans IPO For Personalized Platform

Aug. 27, 2007

Precision Therapeutics Plans IPO For Personalized Platform

Aug. 27, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Nov. 14, 2025.
With transdiagnostic approach, smaller target groups aren’t inevitably smaller markets
BioWorld
Despite the formidable challenges for developing precision psychiatry, the approach is notching its first successes in the preclinical and even some clinical...
With transdiagnostic approach, smaller target groups aren’t inevitably smaller markets
BioWorld Science
Despite the formidable challenges for developing precision psychiatry, the approach is notching its first successes in the preclinical and even some clinical...
Anchoring, and bootstrapping, psychiatry into the precision medicine era
BioWorld Science
Psychiatry has struggled to enter the precision medicine era. But through a mix of innovations and bootstrapping, progress is coming to the field. Scientists are...